Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

about

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

Item

http://www.wikidata.org/entity/Q47800284

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@en

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@nl

type

Item

label

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@en

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@nl

prefLabel

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@en

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@nl

P1476

Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.

@en

P2093

Mohammad Al Qadire

http://www.w3.org/2001/XMLSchema#string

P2860

Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron

Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.

Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting.

Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.

Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments.

Implementation of best practice for chemotherapy-induced nausea and vomiting in an acute care setting.

Delayed Chemotherapy-Induced Nausea and Vomiting in the Hematology Population: A Review of the Literature.

Prevention and management of chemotherapy-induced nausea and vomiting.

Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.

Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study.

P304

730-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1054773817704586

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Al Qadire

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28388860

http://www.w3.org/2001/XMLSchema#string